Atovaquone-Proguanil

Contract SPE2D2-24-D-0005 is a commercial item acquisition awarded by DLA Troop Support to Golden State Medical Supply, Inc. for the procurement of Atovaquone-Proguanil tablets. The contract is a Women-Owned Small Business set-aside with a total estimated value of $20,495,935 over a five-year period, consisting of a base year and four option years. The award includes two primary product configurations: 24-count bottles and 100-count bottles, with estimated annual values of approximately $4,099,187. Performance is managed under FOB Destination terms, and the contract incorporates various FAR and DFARS clauses focusing on supply chain security, business ethics, and sustainable procurement practices. The contract has undergone several modifications to manage its lifecycle and compliance. Modification P00001 exercised Option Year 1 and adjusted the unit price for the 24-count tablets from $35.00 to $33.27. Modification P00002 updated the contract to align with DoD Class Deviations 2025-O0003 and 2025-O0004, specifically revising clauses related to environmental management and sustainable products. Most recently, Modification P00003 exercised Option Year 2, extending the period of performance from April 4, 2026, through April 3, 2027.